FDA Approves First Molecular-Based Lab Test to Detect Metastatic Breast
FDA Approves First Molecular-Based Lab Test to Detect Metastatic Breast Cancer
The GeneSearch BLN Assay detects molecules that are abundant in breast tissue but scarce in a normal lymph node.